Panacea Biotec

Rediff.com » News » Panacea Biotec

News for Panacea Biotec

News
Business

First-ever phase-3 trial for dengue vaccine begins in India

The Indian Council of Medical Research (ICMR) and Panacea Biotec have initiated the first-ever phase three clinical trial for developing a dengue vaccine in India, the Union Health Ministry said on......

India's First Dengue Vaccine Likely To Be Ready By 2026

Dengue has become a major public health concern in India with 289,235 cases reported last year. This year there were 19,447 cases of dengue which resulted in 19 deaths till April 2024. Kindly......

Sputnik V production begins in India; 100mn jabs to be manufactured per year

Domestic pharma major Panacea Biotec in collaboration with Russian sovereign wealth fund Russian Direct Investment Fund (RDIF) has begun the production of 'Sputnik V' COVID-19 vaccine in......

India to produce 850mn Sputnik doses annually: RDIF

The Russian Direct Investment Fund (RDIF) has said more than 850 million doses of the Sputnik V vaccine are going to be produced annually in India, which has also given approval for the emergency......

Russia reaches out to Kerala for Sputnik V plant

The government may look at areas around Thonnakkal, in Thiruvananthapuram district, for the facility. If successful, this would be one of the few sites of Sputnik V owned by Russian firms......

Panacea eyes Latin America

Panacea Biotec is planning to launch its organ transplantation drugs to Latin American and South East Asian markets. The company is also looking for enlarging the scope of organ transplantation......

Panacea gets WHO accreditation for Hep-B vaccine

Panacea Biotec Ltdsaid on Wednesday it has received pre-qualification accreditation from the World Health Organisationfor the supply of recombinant Hepatitis B vaccine to UN agencies.Hepatitis B......

Panacea in pacts with US research body

Delhi-based Panacea Biotec has closed two technology transfer deals with the US medical research agency, National Institute of Health.The licensing deals include a novel technology for a hair......

Panacea to set up Rs 35 cr unit in HP

Delhi-based Panacea Biotec Ltd is commissioning its second plant in Baddi in Himachal Pradesh that will produce US Food and Drug Administration-approved drugs for the regulated markets. The Rs 35......

Sensex falls 251 points; oil and gas shares tumble

Markets ended lower on Friday, amid weakness in European shares, dragged by oil shares because of declining global crude oil prices. Adding to this, investors were cautious ahead of CPI and IIP......

Rediff News

Panacea Biotec

News for Panacea Biotec

First-ever phase-3 trial for dengue vaccine begins in India

India's First Dengue Vaccine Likely To Be Ready By 2026

Sputnik V production begins in India; 100mn jabs to be manufactured per year

India to produce 850mn Sputnik doses annually: RDIF

Russia reaches out to Kerala for Sputnik V plant

Panacea eyes Latin America

Panacea gets WHO accreditation for Hep-B vaccine

Panacea in pacts with US research body

Panacea to set up Rs 35 cr unit in HP

Sensex falls 251 points; oil and gas shares tumble

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS